Related Experiment Video
Updated: Oct 12, 2026

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
Published on: July 11, 2015
Evaluation of inactivated Mycoplasma gallisepticum oil-emulsion bacterins for protection against airsacculitis in
Abstract:
Broiler chicks were vaccinated subcutaneously in the neck at various ages with a single 0.5-ml dose of beta-propiolactone-inactivated Mycoplasma gallisepticum (MG) oil-emulsion bacterin. Four weeks later, vaccinated and control chicks were placed in cold environmental cabinets, infected with infectious bronchitis virus intratracheally, and 2 days later challenged by aerosol exposure to live MG broth culture. All chicks were killed 21 days later and scored postmortem for the rate and severity of airsacculitis produced in each group. Broiler chicks vaccinated at 1 day of age had only slight protection against the development of airsacculitis. Results were variable when chicks were vaccinated at 7 days of age, with little evidence of resistance to airsacculitis. However, when broiler chicks were vaccinated with MG bacterins at 11 to 15 days of age, they acquired significant protection against airsacculitis compared with controls. Viable MG organisms were readily isolated from most of the sampled tracheas and air-sac lesions cultured 21 days post-challenge, indicating a lack of protection against infection of the respiratory tract. MG-vaccinated chicks generally produced antibodies readily detectable by the rapid serum-plate test, tube-agglutination, and hemagglutination-inhibition (HI) tests. Some of the vaccinated chicks, but none of the unvaccinated control chicks, developed positive reactions to agar-gel-precipitin tests following challenge. Low HI titers at challenge were not necessarily indicative of lack of protection against the development of airsacculitis, since good protection was often observed in chickens with low to moderate HI titers.
More Related Videos
07:32Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection
Published on: September 1, 2023
06:57Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023